SCHEMBL10135386

SCHEMBL10135386

Cc1cc2oc3c(O)c(O)c(C)cc3c2c(=O)o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.50
MAPT P10636 7/20 0.48
MEN1 O00255 6/20 0.48
KMT2A Q03164 6/20 0.48
PTGS1 P23219 2/20 0.41
PTGS2 P35354 2/20 0.41
ANTXR2 P58335 1/20 0.41
CLK2 P49760 1/20 0.40
MAOA P21397 2/20 0.40
NQO1 P15559 1/20 0.39
CYP3A4 P08684 5/20 0.38
RECQL P46063 3/20 0.38
HSD17B10 Q99714 2/20 0.38
KLK7 P49862 1/20 0.38
KLK5 Q9Y337 1/20 0.38
PKM P14618 1/20 0.38
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
LMNA P02545 3/20 0.37
GAA P10253 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10135388 0.89 KDM4E (0.49) KDM4EMAPTMEN1KMT2APTGS1
SCHEMBL10181450 0.88 PTGS1 (0.51) KDM4EMAPTMEN1KMT2APTGS1
SCHEMBL10135381 0.84 KDM4E (0.52) KDM4EMAPTMEN1KMT2APTGS1
SCHEMBL10181770 0.82 KMT2A (0.43) KDM4EMAPTMEN1KMT2APTGS1
SCHEMBL10135390 0.81 KDM4E (0.46) KDM4EMAPTMEN1KMT2APTGS1
SCHEMBL581188 0.80 KDM4E (0.59) KDM4EMAPTMEN1KMT2APTGS1
SCHEMBL580976 0.78 KDM4E (0.44) KDM4EMAPTMEN1KMT2APTGS1
SCHEMBL10181689 0.77 KMT2A (0.42) KDM4EMAPTMEN1KMT2APTGS1
SCHEMBL10135410 0.76 PGAM1 (0.40) KDM4EMAPTMEN1KMT2AESR1
SCHEMBL10135382 0.76 KDM4E (0.60) KDM4EMAPTMEN1KMT2APTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859235-B2 Methods in cell cultures, and related inventions, employing certain additives BASF SE (DE) 2014-10-14 US disclosed
US-8383088-B2 Coumestan-like antioxidants and UV absorbants BASF SE (DE) 2013-02-26 US disclosed
US-20120164162-A1 METHODS IN CELL CULTURES, AND RELATED INVENTIONS, EMPLOYING CERTAIN ADDITIVES BASF SE (DE) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120164162-A1 METHODS IN CELL CULTURES, AND RELATED INVENTIONS, EMPLOYING CERTAIN ADDITIVES BBOX1, NEFM, NQO1 KDM4E 715/4885MAPT 4807/4885MEN1 3694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.